<!-- mobian-agent-page publisher="dailydev" canonical="https://daily.dev/posts/the-biotech-ai-revolution-is-nearly-here-in-2024-af9ii5c3q" -->

---
title: The Biotech AI Revolution is Nearly Here in 2024 | daily.dev
description: Insilico Medicine is a biotech company that uses AI in drug discovery and development. They are developing drugs for various diseases and have a focus on drug...
canonical: https://daily.dev/posts/the-biotech-ai-revolution-is-nearly-here-in-2024-af9ii5c3q
twitter:card: summary_large_image
twitter:site: @dailydotdev
og:type: website
og:site_name: daily.dev
og:title: The Biotech AI Revolution is Nearly Here in 2024 | daily.dev
og:description: Insilico Medicine is a biotech company that uses AI in drug discovery and development. They are developing drugs for various diseases and have a focus on drug...
og:url: https://daily.dev/posts/the-biotech-ai-revolution-is-nearly-here-in-2024-af9ii5c3q
og:image: https://api.daily.dev/og/posts/Af9II5c3Q.png
og:image:alt: The Biotech AI Revolution is Nearly Here in 2024
og:image:width: 1200
og:image:height: 630
og:locale: en
---

> ## Documentation Index
> Fetch the complete documentation index at: https://daily.dev/llms.txt
> Use this file to discover all available pages before exploring further.

# The Biotech AI Revolution is Nearly Here in 2024

**[Substack](https://daily.dev/sources/substack)** · 18 min read · 2 upvotes · 0 comments

## Summary

Insilico Medicine is a biotech company that uses AI in drug discovery and development. They are developing drugs for various diseases and have a focus on drug repurposing. Insilico Medicine uses AI platforms like PandaOmics, Chemistry42, and inClinico. They have collaborated with companies like GSK, Pfizer, and Novo Nordisk. The company has a high valuation and has raised significant funding. They also have an Intelligent Robotics Drug Discovery Laboratory. The use of AI in drug discovery offers advantages in efficiency and cost reduction. The study published by Insilico Medicine in Nature Biotechnology is significant in demonstrating the translation of AI-predicted findings into clinical trials. The Vice President of Business Development at Insilico Medicine is Keith Mikule.

## Full article

daily.dev links to this article rather than hosting it. Read it at the original source: <https://www.ai-supremacy.com/p/the-biotech-ai-revolution-is-nearly>

---

Tags: [#ai](https://daily.dev/tags/ai), [#biotech](https://daily.dev/tags/biotech), [#genai](https://daily.dev/tags/genai), [#nvidia](https://daily.dev/tags/nvidia), [#quantum-computing](https://daily.dev/tags/quantum-computing), [#robotics](https://daily.dev/tags/robotics)

[View this post on daily.dev](https://daily.dev/posts/the-biotech-ai-revolution-is-nearly-here-in-2024-af9ii5c3q)

```json
{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://daily.dev/#organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180},"sameAs":["https://twitter.com/dailydotdev","https://github.com/dailydotdev","https://www.linkedin.com/company/daily-dev-ltd"]},{"@type":"WebSite","@id":"https://daily.dev/#website","url":"https://daily.dev","name":"daily.dev","publisher":{"@id":"https://daily.dev/#organization"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://daily.dev/search?q={search_term_string}"},"query-input":"required name=search_term_string"}}]}
{"@context":"https://schema.org","@type":"TechArticle","headline":"The Biotech AI Revolution is Nearly Here in 2024","url":"https://daily.dev/posts/the-biotech-ai-revolution-is-nearly-here-in-2024-af9ii5c3q","mainEntityOfPage":{"@type":"WebPage","@id":"https://daily.dev/posts/the-biotech-ai-revolution-is-nearly-here-in-2024-af9ii5c3q"},"datePublished":"2024-05-03T06:06:24.371Z","dateModified":"2026-03-15T03:39:36.508Z","description":"Insilico Medicine is a biotech company that uses AI in drug discovery and development. They are developing drugs for various diseases and have a focus on drug...","image":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/c75daa08fcaa98463aa540e163406db0?_a=AQAEuiZ","thumbnailUrl":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/c75daa08fcaa98463aa540e163406db0?_a=AQAEuiZ","isAccessibleForFree":true,"articleSection":"Substack","inLanguage":"en","publisher":{"@type":"Organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180}},"author":{"@type":"Organization","name":"Substack","logo":"https://media.daily.dev/image/upload/s--KFqxX_OL--/f_auto,t_logo/v1698154293/logos/substack.jpg","url":"https://daily.dev/sources/substack"},"commentCount":0,"discussionUrl":"https://daily.dev/posts/the-biotech-ai-revolution-is-nearly-here-in-2024-af9ii5c3q","interactionStatistic":[{"@type":"InteractionCounter","interactionType":{"@type":"LikeAction"},"userInteractionCount":2},{"@type":"InteractionCounter","interactionType":{"@type":"CommentAction"},"userInteractionCount":0}],"keywords":"ai,biotech,genai,nvidia,quantum-computing,robotics","timeRequired":"PT18M"}
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://daily.dev"},{"@type":"ListItem","position":2,"name":"Substack","item":"https://daily.dev/sources/substack"},{"@type":"ListItem","position":3,"name":"The Biotech AI Revolution is Nearly Here in 2024"}]}
```

